Please provide your email address to receive an email when new articles are posted on . Rheumatologists treating patients with systemic lupus erythematosus should focus more on hydroxychloroquine ...

Prolonged remission was observed in 72% of patients with systemic lupus erythematosus (SLE) who were treated with a consistent 200 mg daily dose of hydroxychloroquine. The mean weight-adjusted ...

The mutagenic potential of hydroxychloroquine has not been evaluated. However, chloroquine has been shown to be a catalytic inhibitor of DNA repair enzymes (topoisomerase II) and to produce weak ...

BARCELONA, Spain — Monitoring blood hydroxychloroquine levels could help to ensure that patients with systemic lupus erythematosus (SLE) are being treated with the drug optimally, according to ...

Greater risks of toxic effects were found at higher methotrexate doses and lower eGFR. Older patients with chronic kidney disease (CKD) starting low-dose methotrexate rather than hydroxychloroquine ...

Hydroxychloroquine (Plaquenil®) is the most prescribed medication for symptoms of lupus. The drug is available in one strength (200 mg tablets). The Lupus Foundation of America conducted a survey to ...